These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25250863)

  • 1. The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement Network.
    Cea Soriano L; Wallander MA; Andersson S; Filonenko A; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2015 Jan; 24(1):52-8. PubMed ID: 25250863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of long-acting reversible contraceptives in the UK from 2004 to 2010: analysis using The Health Improvement Network Database.
    Cea Soriano L; Wallander MA; Andersson S; Filonenko A; García Rodríguez LA
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):439-47. PubMed ID: 25139412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of long-acting reversible contraceptive use in a UK primary care database: validation of methodology.
    Cea Soriano L; Wallander MA; Andersson SW; Requena G; García-Rodríguez LA
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):22-8. PubMed ID: 24229345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of prescription contraceptive methods in the UK general population: a primary care study.
    Cea-Soriano L; García Rodríguez LA; Machlitt A; Wallander MA
    BJOG; 2014 Jan; 121(1):53-60; discussion 60-1. PubMed ID: 24118863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database.
    Agostini A; Godard C; Laurendeau C; Benmahmoud Zoubir A; Lafuma A; Lévy-Bachelot L; Gourmelen J; Linet T
    Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):421-426. PubMed ID: 30499732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya.
    Hubacher D; Masaba R; Manduku CK; Chen M; Veena V
    Contraception; 2015 Apr; 91(4):295-300. PubMed ID: 25601351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of long-acting reversible contraception users in Europe.
    Haimovich S
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):187-95. PubMed ID: 19565416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
    Mavranezouli I;
    Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and performance of the levonorgestrel-releasing intrauterine system.
    Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
    Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for Brazilian women to switch from different contraceptives to long-acting reversible contraceptives.
    Ferreira JM; Nunes FR; Modesto W; Gonçalves MP; Bahamondes L
    Contraception; 2014 Jan; 89(1):17-21. PubMed ID: 24156884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction.
    Diedrich JT; Desai S; Zhao Q; Secura G; Madden T; Peipert JF
    Am J Obstet Gynecol; 2015 Jan; 212(1):50.e1-8. PubMed ID: 25046805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use.
    Modesto W; de Nazaré Silva dos Santos P; Correia VM; Borges L; Bahamondes L
    Eur J Contracept Reprod Health Care; 2015 Feb; 20(1):57-63. PubMed ID: 25160484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
    Rose SB; Garrett SM; Stanley J
    Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
    Weisberg E; Bateson D; McGeechan K; Mohapatra L
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):5-14. PubMed ID: 24229367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young women's attitudes towards, and experiences of, long-acting reversible contraceptives.
    Bracken J; Graham CA
    Eur J Contracept Reprod Health Care; 2014 Aug; 19(4):276-84. PubMed ID: 24882426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.
    Hubacher D; Masaba R; Manduku CK; Veena V
    Contraception; 2013 Jul; 88(1):97-102. PubMed ID: 23566383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.